A clinical trial titled "Effects of Acetyl L-Carnitine Supplementation on Clinical, Metabolic and Inflammatory Symptoms in Obese, Diabetic, Postmenopausal Women With Osteoarthritis" has been updated to a status of completed as of September 17, 2026.
The trial, registered under identifier NCT07660081, is listed with a phase designation of not applicable. The study status change was recorded on the date noted above according to the clinical trial registry.
This update reflects only the current status of the trial as posted. No results, outcomes, or efficacy data are included in this status update. The registry entry does not indicate whether findings have been published or what conclusions, if any, were reached.
This news item is associated with the compound corticotropin, which carries an approved regulatory status. Readers should note that the trial title concerns Acetyl L-Carnitine supplementation and its listed population, as specified in the registry record.
For additional background on corticotropin, including its regulatory status and general information, readers can consult the compound overview.